Fujifilm Irvine Scientific establishes innovation center in China

By The Science Advisory Board staff writers

December 3, 2021 -- Fujifilm Irvine Scientific will establish an innovation and collaboration Center in Suzhou New District, China. The new center will allow Fujifilm to collaborate with customers and design upstream cell culture processes that meet customers' biomanufacturing needs.

The world has seen rapid growth in China's biopharmaceutical, vaccine, and cell and gene therapy markets. The speed of approval of biosimilar drugs and investment by the Chinese government to make more affordable drugs available to its people is accelerating that growth, Fujifilm said. Accordingly, the market for cell culture media in China is expected to grow at an annual rate of about 20%, according to the firm.

The center will incorporate advanced cell culture automation and analysis into process and media development to enable highly accurate evaluation and identification of optimal upstream cell culture processes. Furthermore, it will provide resources and expertise for optimized cell culture media and associated workflows to achieve the quantity and product quality attributes necessary to support commercial production of new drugs, Fujifilm added.

The new center joins other Fujifilm facilities that are in the U.S. and Japan. Construction of the center has begun and is expected to be completed by March 2022.

With Hitachi deal done, Fujifilm sets sights on healthcare growth
Fresh off its acquisition of Hitachi's medical imaging business, Japanese industrial giant Fujifilm on July 1 rebranded its healthcare subsidiaries in...
Fujifilm picks Holly Springs for new facility
Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization for biologics, viral vaccines, and gene therapies, announced...
Fujifilm invests $2B on cell culture manufacturing
Fujifilm plans to invest more than $2 billion to build a large-scale cell culture manufacturing site for biopharmaceuticals in the U.S.
Irvine Scientific to exclusively distribute stem cell tech
Fujifilm Irvine Scientific said it has become the exclusive worldwide distributor of cellnest, a recombinant peptide attachment substrate that's designed...

Copyright © 2021 scienceboard.net

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter